United Maritime Corp current report, Q3 FY2022

United Maritime Corporation — Form 6-K Summary

Business Context and Reporting Period

United Maritime Corporation filed this Form 6-K for July 2022, dated July 20, 2022. The filing reports the pricing and documentation of a public securities offering conducted on July 18, 2022.

Offering and Key Financial Terms

  • The Company offered 8,000,000 units at $3.25 per unit, for aggregate gross proceeds of approximately $26.0 million before offering expenses.
  • Each unit consisted of one common share, or a pre-funded warrant in lieu of a common share, and one Class A warrant to purchase one common share.
  • The offering was conducted pursuant to a securities purchase agreement with unaffiliated institutional investors.
  • Maxim Group LLC acted as sole placement agent.
  • The filing does not provide net proceeds, placement-agent fees, warrant exercise price, warrant expiration date, or use of proceeds.
  • As of the filing date, 8,862,004 common shares were issued and outstanding, reflecting the exercise of certain pre-funded warrants issued in the offering.

Material Changes Versus the Prior Comparable Period

The filing does not provide comparative financial statements or operating results. The material reported change is the completion of the $26.0 million public offering and the resulting common-share issuance associated with exercises of certain pre-funded warrants.

Guidance, Outlook, Risks, and Unusual Items

  • No earnings guidance or operating outlook is provided.
  • The offering may result in dilution to existing shareholders from the issuance of common shares and potential future exercises of Class A warrants and remaining pre-funded warrants.
  • Additional securities and warrant terms are contained in the filed placement agency agreement, securities purchase agreement, warrant agency agreement, and warrant forms.
  • The filing does not describe specific contingencies or unusual operating items beyond the offering.

Investor Verification Checklist

  • Verify the final number of common shares issued and outstanding after all pre-funded warrant exercises.
  • Review the Class A warrant exercise price, expiration, adjustment provisions, and potential dilution.
  • Confirm gross-to-net proceeds and the Company’s intended use of offering proceeds.
  • Review the securities purchase agreement and placement agency agreement for closing conditions, fees, representations, and investor rights.
  • Confirm whether all 8,000,000 units were issued as common shares or partly as pre-funded warrants.